RWRichard Wang

Richard Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Richard Wang has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • First‐line infusion therapies in refractory status epilepticus: A retrospective comparison of outcomes between midazolam and propofol in 7446 patients

    by Isaac B. Thorman, Ariel Sacknovitz, Richard Wang, Patricia E. McGoldrick, Michael C. Schubert, Stephan A. Mayer, Carrie R. Muh, Steven M. Wolf

    Objective: Refractory status epilepticus (RSE) is a medical emergency defined as “status epilepticus persisting despite administration of at least 2 appropriately selected and dosed parenteral medications including a benzodiazepine.” Control of RSE is critical to avoid irreversible neuronal damage, with midazolam and propofol as the most commonly used agents. This study evaluates the effectiveness of midazolam versus propofol in preventing mortality and complications of RSE. Methods: Patients from the TriNetX Research Network who received either midazolam or propofol monotherapy on the day of RSE onset were included. Outcomes were assessed at 30 days and maximal follow‐up (≤20 years) using Cox proportional hazard models. Propensity score matching (1:1) controlled for demographics and 93 comorbidities from the Charlson Comorbidity Index. Results: Among 117 736 patients with RSE, 5310 received midazolam and 2136 received propofol. Midazolam was associated with significantly decreased hazards of mortality at 30 days (HR = 0.509 [95% CI: 0.397, 0.653]) but not at maximal follow‐up (HR = 0.922 [0.797, 1.067]). Midazolam was also associated with significantly reduced hazards of lactic acidosis (HR = 0.537 [0.427, 0.674]), rhabdomyolysis (HR = 0.295 [0.150, 0.578]), hypertriglyceridemia (HR = 0.316 [0.135, 0.740]), tracheostomy (HR = 0.633 [0.438, 0.916]), PEG placement (HR = 0.519 [0.371, 0.725]), and mechanical ventilation (HR = 0.313 [0.265, 0.370]). Among patients with a traumatic brain injury in the week prior to RSE, midazolam was associated with a significantly lower hazard of 30‐day mortality (HR = 0.381 [0.136, 0.993]), while the hazards were not significantly changed in patients with CNS infections (HR = 1.150 [0.351, 3.768]) or cerebrovascular disease (HR = 0.656 [0.421, 1.025]) in the week prior to RSE onset. Significance: Midazolam monotherapy for RSE was associated with decreased mortality and adverse effects compared to propofol monotherapy in the short term, but relatively equivalent in the long term. Prospective comparative trials are needed to ascertain superiority of either intervention in reducing morbidity and mortality in patients with RSE.


  • Open Access

    Novel case of pediatric basal ganglia abscess due to Streptococcus intermedius amid a rise in neuroinvasive infections during the COVID-19 pandemic: illustrative case

    by Rebecca Strafella, Shoaib A. Syed, Ariel Sacknovitz, Richard Wang, Shaye Busse, Avinash Mohan

    BACKGROUND: Pediatric basal ganglia abscesses are extremely rare, with only 2 other published cases in the literature. To the authors’ knowledge, this is the first case of a primary bacterial abscess caused by Streptococcus intermedius in the basal ganglia of a pediatric patient. OBSERVATIONS: This case coincides with a rise in neuroinvasive streptococcal infections among children during the COVID-19 pandemic. Prompt MRI with diffusion and attenuation analyses allowed for abscess identification and treatment with neurosurgical drainage, leading to full recovery. Although intracranial abscesses in deep parenchymal locations are extremely rare in healthy children, the recently increased incidence of neuroinvasive infections and the devastating sequelae of delayed or missed diagnosis make early recognition and treatment essential. To this end, reporting and recognition of the varied presentations of this pathology is crucial. LESSONS: Herein, the authors highlight that in light of the surge in cases in recent years, patients suspected of having an intracranial abscess should not be delayed in receiving cranial imaging and treatment, as rapid identification and management of abscesses are crucial to reduce the likelihood of long-term complications. https://thejns.org/doi/10.3171/CASE24562

  • Open Access

    Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review

    by Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf


  • Risk factors and outcomes of cardiac arrest in pediatric traumatic brain injury patients

    by Irim Salik, Sima Vazquez, Nisha Palla, Norbert Smietalo, Richard Wang, Monica Vavilala, Jose F. Dominguez, Iwan Sofjan, Jared M. Pisapia

  • Open Access

    Bilateral pulvinar responsive neurostimulation for bilateral multifocal posteriorly dominant drug resistant epilepsy

    by Richard Wang, Ariel Sacknovitz, Sima Vazquez, Jose Dominguez, Patty McGoldrick, Steven Wolf, Vishad Sukul, Carrie Muh, Sanjay E. Patra, David E. Burdette

    Objective: To describe four cases of Responsive Neurostimulation (RNS) in the bilateral pulvinar nuclei (PUL) in individuals with drug resistant epilepsy (DRE). This will show that due to widespread PUL connectivity, bilateral PUL RNS may be an option for some individuals with bilateral multifocal epilepsy.Methods: This study comprises two centers' experience with bilateral PUL RNS for DRE. Patients treated with bilateral PUL RNS at Westchester Medical Center (Valhalla, NY) and Corewell Health (Grand Rapids, MI) between the years 2019 and 2022 were analyzed and described. Presented here are methods for target selection, device programming, and clinical outcomes.Results: Two patients with Lennox–Gastaut phenotype (aged 13 and 21 years) with posteriorly dominant discharges were implanted with bilateral PUL electrodes. Additionally, two patients (aged 20 and 31 years) with independent left and right occipital bilateral multifocal seizure onsets were implanted with bilateral RNS devices targeting the ipsilateral PUL and ipsilateral occipital cortex. Subclinical and clinical seizures were captured by RNS electrocorticography (ECoG) in all patients. RNS implantation and treatment was well‐tolerated without adverse effects in all patients. Relative to baseline, two patients had 25% and 50% reduction in disabling seizures, and two patients had 71% and 100% reduction in disabling seizures. Stimulation paradigms utilized high frequency stimulation in both Lennox–Gastaut phenotype patients. Low frequency (individualized to the terminal ictal frequencies) stimulation was effective in the two bioccipital patients.Significance: RNS with electrode placement targeting bilateral PUL is safe, and no adverse effects have been attributable to the pulvinar electrode placement. PUL responsive neurostimulation is potentially effective for patients with bilateral multifocal, posteriorly dominant DRE. Both high and low frequency responsive stimulation are treatment options. Longer follow‐up will shed light on the ultimate reduction of seizure burden.Plain Language Summary: We describe four cases where stimulation devices were placed in the Pulvinar area of the thalamus (central sensory area in the brain). This is very unique and different location than where these devices are typically placed. These patients all had great outcomes with marked seizure reduction, demonstrating that this placement is both safe and effective.


  • Open Access

    Overcoming Graft Rejection in Induced Pluripotent Stem Cell-Derived Inhibitory Interneurons for Drug-Resistant Epilepsy

    by Cameron P. Beaudreault, Richard Wang, Carrie Rebecca Muh, Ashley Rosenberg, Abigail Funari, Patty E. McGoldrick, Steven M. Wolf, Ariel Sacknovitz, Sangmi Chung

    Background: Cell-based therapies for drug-resistant epilepsy using induced pluripotent stem cell-derived inhibitory interneurons are now in early-phase clinical trials, building on findings from trials in Parkinson’s disease (PD) and Huntington’s disease (HD). Graft rejection and the need for immunosuppressive therapy post-transplantation pose potential barriers to more epilepsy patients becoming potential candidates for inhibitory interneurons transplantation surgery. Objectives: The present literature review weighs the evidence for and against human leukocyte antigen (HLA)-mediated graft rejection in PD and HD and examines the potential advantages and drawbacks to five broad approaches to cell-based therapies, including autologous cell culture and transplantation, in vivo reprogramming of glial cells using viral vectors, allogeneic transplantation using off-the-shelf cell lines, transplantation using inhibitory interneurons cultured from HLA-matched cell lines, and the use of hypoimmunogenic-induced pluripotent stem cell-derived inhibitory interneurons. The impact of surgical technique and associated needle trauma on graft rejection is also discussed. Methods: Non-systematic literature review. Results: While cell-based therapies have enjoyed early successes in treating a host of central nervous system disorders, the immunologic reaction against surgical procedures and implanted materials has remained a major obstacle. Conclusions: Adapting cell-based therapies using iPSC-derived inhibitory interneurons for epilepsy surgery will similarly require surmounting the challenge of immunogenicity.


  • Open Access

    Association of reductions in rescue medication requirements with vagus nerve stimulation: Results of long-term community collected data from a seizure diary app

    by Cameron P. Beaudreault, Sharon Chiang, Ariel Sacknovitz, Robert Moss, Paige Brabant, David Zuckerman, Jessica R. Dorilio, Eris Spirollari, Alexandria F. Naftchi, Patricia E. McGoldrick, et al.


  • Open Access

    Sudden unexpected death in epilepsy in a patient with a brain‐responsive neurostimulation device

    by Richard Wang, Patricia E. McGoldrick, Galadu Subah, Carrie R. Muh, Steven M. Wolf

    Background: Sudden unexpected death in epilepsy (SUDEP) is the most common cause of epilepsy‐related mortality. Although most witnessed SUDEPs follow seizures, mechanisms are uncertain. Investigations into the pathophysiology of SUDEP have relied on models and rare recordings of brain function at the time of the event. The brain‐responsive neurostimulation (RNS) device from Neuropace offers a therapeutic option for drug‐refractory epilepsy (DRE), enabling the recording of brain activity and the preemptive termination of seizures. Therefore, patients who experience SUDEP while being treated with an RNS device can provide insights into neural activity at the moment of this event.Objective: We report the history and electrocorticographic (ECoG) recordings of a patient with DRE who experienced SUDEP years after RNS placement.Patient History: A girl with Phelan–McDermid syndrome and Lennox–Gastaut syndrome had an RNS device implanted at the age of 14 to treat DRE. Initially, electrodes were positioned in the right orbitofrontal (OF) and right premotor frontal regions, with the OF lead later changed to the centromedian thalamic nucleus. At age 19, the patient was found unconscious and in cardiac arrest by her parents. Although spontaneous circulation returned en route to the hospital, the patient did not regain consciousness and died. Subsequent analysis of ECoGs from RNS recordings at the time of death indicated seizure onset in the right premotor frontal cortex, which persisted despite seizure termination attempts by the RNS.Conclusions: We present a patient with SUDEP associated with the onset of RNS‐refractory seizures. The significance of this report is highlighted by the rarity of literature on neuronal function at the time of SUDEP. Moreover, it underscores the potential for devices capable of monitoring ECoG activity to shed light on the mechanisms underlying SUDEP and to inform interventions.


  • Characteristics of Patients Selected for Surgical Treatment of Spinal Meningioma

    by Eris Spirollari, Sima Vazquez, Ankita Das, Richard Wang, Leonel Ampie, Austin B. Carpenter, Sabrina Zeller, Alexandria F. Naftchi, Cameron Beaudreault, Tiffany Ming, et al.